Newsletter
June 12, 2019
Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes
ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:
(i) the cultivation of the cannabis spp. for medical and scientific purposes; and
(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.
For further information, click below to access our full newsletter.
Last related news
November 21, 2023
The protection of IP rights in the new Brazilian sports law
The enactment of Law No. 14,597/2023 (known as General Sports Law – GSL) in June of this year marks a milestone for … The protection of IP rights in the new Brazilian sports law
November 7, 2023
Brazilian Finance Ministry Issues New Regulation For Sports Betting Market
On October 27, the Brazilian Finance Ministry (MF) issued a significant regulatory milestone for sports betting activities (Ordinance No. 1,300/2023) which establishes the … Brazilian Finance Ministry Issues New Regulation For Sports Betting Market
October 30, 2023
ANVISA’s Personal Data Protection Policy is released
On October 19, 2023, the Federal Official Gazette (DOU) published Administrative Order 1,184/2023, which provides for the National Health Surveillance Agency’s (Anvisa) … ANVISA’s Personal Data Protection Policy is released